MXPA05011942A - Aminas sustituidas con biciclico fundido, como ligandos del receptor de histamina-3. - Google Patents

Aminas sustituidas con biciclico fundido, como ligandos del receptor de histamina-3.

Info

Publication number
MXPA05011942A
MXPA05011942A MXPA05011942A MXPA05011942A MXPA05011942A MX PA05011942 A MXPA05011942 A MX PA05011942A MX PA05011942 A MXPA05011942 A MX PA05011942A MX PA05011942 A MXPA05011942 A MX PA05011942A MX PA05011942 A MXPA05011942 A MX PA05011942A
Authority
MX
Mexico
Prior art keywords
group
histamine
receptor ligands
alkyl
fused bicyclic
Prior art date
Application number
MXPA05011942A
Other languages
English (en)
Inventor
Robert A Altenbach
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/431,152 external-priority patent/US20040224952A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MXPA05011942A publication Critical patent/MXPA05011942A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Los compuestos de la formula (I) son utiles para tratar condiciones o trastornos prevenidos por o mejorados por los ligandos del receptor de histamina-3. Tambien estan descritas composiciones farmaceuticas que comprende los ligandos del receptor de histamina-3, y metodos para usar dichos compuestos y composiciones. X es O, S. NH o N(alquilo); Y y Y', cada no independientemente, estan seleccionados del grupo que consiste de CH, CF y N; Z es C o N, a condicion de que cuando X es O o S, Z es N; uno de R1 y R2 esta seleccionado del grupo que consiste de arilo, heteroarilo y heterociclo; el otro de R1 y R2 esta seleccionado del grupo que consiste de hidrogeno, alquilo, alcoxi, arilo, cicloalquilo, halo, ciano y tioalcoxi; R3 esta ausente cuando Z es N y, cuando esta presente, R3 esta seleccionado del grupo que consiste de hidrogeno, metilo, alcoxi, halo y ciano; cada uno de R4 y R5 esta seleccionado independientemente del grupo que consiste de alquilo, haloalquilo, hidroxialquilo, alcoxialquilo, cicloalquilo y cicloalquilalquilo; o R4 y R5, tomados junto con el atomo de nitrogeno al que cada uno esta unido, forman un anillo no aromatico; L es -[C(R15(R16)n-; m es un entero de 0 a 3 y n es un entero de 2 a 3.
MXPA05011942A 2003-05-07 2004-05-03 Aminas sustituidas con biciclico fundido, como ligandos del receptor de histamina-3. MXPA05011942A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/431,152 US20040224952A1 (en) 2003-05-07 2003-05-07 Fused bicyclic-substituted amines as histamine-3 receptor ligands
US10/670,629 US20040224953A1 (en) 2003-05-07 2003-09-25 Fused bicyclic-substituted amines as histamine-3 receptor ligands
PCT/US2004/013606 WO2004101559A1 (en) 2003-05-07 2004-05-03 Fused bicyclic-substituted amines as histamine-3 receptor ligands

Publications (1)

Publication Number Publication Date
MXPA05011942A true MXPA05011942A (es) 2006-02-02

Family

ID=33456528

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011942A MXPA05011942A (es) 2003-05-07 2004-05-03 Aminas sustituidas con biciclico fundido, como ligandos del receptor de histamina-3.

Country Status (4)

Country Link
EP (1) EP1620434B1 (es)
CA (1) CA2524787A1 (es)
MX (1) MXPA05011942A (es)
WO (1) WO2004101559A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101410385B (zh) 2006-03-28 2011-08-24 高点制药有限责任公司 具有组胺h3受体活性的苯并噻唑类
US7507736B2 (en) * 2007-02-07 2009-03-24 Hoffmann-La Roche Inc. Indol-2-yl-piperazin-1-yl-methanone derivatives
CN115028597B (zh) * 2022-04-29 2024-03-26 闽都创新实验室 一种tempo连续脱氢环化制备苯并恶唑类衍生物的方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1370546A2 (en) * 2001-03-16 2003-12-17 Abbott Laboratories Novel amines as histamine-3 receptor ligands and their therapeutic applications
WO2004043458A1 (en) * 2002-11-12 2004-05-27 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands

Also Published As

Publication number Publication date
CA2524787A1 (en) 2004-11-25
WO2004101559A1 (en) 2004-11-25
EP1620434B1 (en) 2011-03-09
EP1620434A1 (en) 2006-02-01

Similar Documents

Publication Publication Date Title
ATE501141T1 (de) Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden
IL189069A0 (en) Piperidine and piperazine derivatives as p2x3 antagonists
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
RS20060316A (en) Derivatives of n-/heteroaryl(piperidine-2-yl)methyl/ benzamide, preparation method and application of same in therapeutics
WO2003080580A3 (en) Quinoline derivatives and their use as 5-ht6 ligands
NZ601220A (en) Hepatitis c virus inhibitors
RS20060317A (en) Derivatives of n-/phenyl(alkylpiperidine-2-yl)methyl/ benzamide, preparation method thereof and application of same in therapeutics
NO20065830L (no) Substituerte 2-kinolyloksazoler som er anvendbare som PDE4-inhibitorer.
CA2615022A1 (en) Hcv ns3 protease inhibitors
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
TW200609670A (en) Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof
WO2008136444A1 (ja) 縮合複素環誘導体
RU2009146124A (ru) Дигидрохиноновые и дигидронафтиридиновые ингибиторы киназы jnk
WO2008006969A3 (fr) Nouveaux derives tetracycuques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2008006625A3 (en) Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
IL102367A (en) Triazolopyrimidine derivatives which are angiotensin ii receptor antagonists, processes for preparing them and pharmaceutical compositions containing them
TNSN07439A1 (en) Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics
TNSN08161A1 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
MX2009004006A (es) Derivados de indol novedosos, proceso para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
MXPA05011942A (es) Aminas sustituidas con biciclico fundido, como ligandos del receptor de histamina-3.
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
MY139011A (en) Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or assignment